What is Microfluidics Technology?
Microfluidics is the study of systems which involve processing of small quantities of fluids by using tiny channels of microscale dimensions. It comprises of behavioural study of fluids through micro-channels. It is also known as technology which uses chambered microminiaturized devices to diagnose fluids flow. It deals with very small volumes of fluids i.e. femtoliters (fL) a quadrillionth of a lit. Microfluidic technology couples multidisciplinary fields by covering physics, chemistry, engineering, and biotechnological areas. This technology encompasses this areas and apply it to study behavioural analysis of small amounts of fluids. This technology widely used in research laboratories and pharmaceutical companies for drug discovery, cell based assays, number of screenings, molecular diffusion coefficients measurements, pH, and fluid viscosity. The major advantages associated with the technology is rapid and accurate response and cost-effectiveness. Hence, the combination of microfluidics in diagnostics techniques is expected to contribute for improvisation in clinical research areas. Microfluidics technology has broad range of applications in number of therapeutics areas. It is mostly used for cancer tumour and pathogen detection. Thus, the increase in chronic diseases like Diabetes and Cancer is anticipated to fuel the growth of the market owing to rise in the demand for screening of these diseases.
The market study is broken down by Type (Device, • Spiral Microfluidic device, • Straight Channel Microfluidic Device, • Y-Channel Microfluidic Device, • Cross-Junction Microfluidic Device, • Others, Chip, • Microfluidic chips, • Lab-on-a-chip, • Organs-on-chips and • Others), by Application (Clinical Formulations Testing, Medicine Diagnosis, Cell Culture & 3D Printing, In-Vitro Diagnosis and Others) and major geographies with country level break-up.
The market of Microfluidics Technology is expected to grow with rising end users such as diagnostic centers, pharmaceutical companies and others. Market specifically witnessing huge demand from healthcare and pharmaceutical industries. Though high cost and requirement of technically keen handling is creating burden on the market. Major players in the industry are CMC Microsystems, Dolomite Microfluidics, other competitive players are gaining attention from the market. Research Analyst at AMA estimates that Players from North America will contribute to the maximum growth of Global Microfluidics Technology market throughout the predicted period.
Abbott Laboratories (United States), Perkinelmer (United States), Cepheid (United States), Raindance Technologies(United States), Becton (United States), Bio-Rad Laboratories (United States), Boston MicroFluidics, Inc. (United States), Life Technologies Corporation (United States), Microfluidic Chipshop GMBH (Germany) and Siemens Healthcare(Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Koninklijke Philips N.V. (Netherlands) and NanoEnTek Inc. (South Korea).
AdvanceMarketAnalytics has segmented the market of Global Microfluidics Technology market by Type, Application and Region.
On the basis of geography, the market of Microfluidics Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Material , the sub-segment i.e. PDMS (Special Silicon) will boost the Microfluidics Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Diagnostics Centres will boost the Microfluidics Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In 2017, Microfluidics International Corporation has launched the new M-815 Biopharma Microfluidizer. It is pilot-scale processor for processing clinical and production cGMP batches. This is providing a unique solution to maintaining consistent process pressure which ensures quality and accuracy.
- Inclination towards the Use of Cost Efficient Lab-On-A-Chip Has Been Raised
- Rising demand for Microfluidics Technology in Diagnostics Market
- Increased Preference for Fluid Based Diagnosis Owing To Accuracy in Results
- Rising Investments for Clinical Research Has Created Opportunity for the Market
- Growing Infrastructure of Diagnostics Centers
- Less Efficient & Difficultly in Handling of Paper Based Microfluidic Devices
- Limitations in Optical Detections in Silicon based Microfluidic chips
- Complex Fabrication Process
Key Target AudienceMicrofluidics Technology Manufacturers Suppliers and Distributors, Venture Capitalists and Private Equity Firms, New Entrants/Investors, Strategic Business Planners, Government Regulatory, Research Organizations and End-Use Industries
About ApproachDuring this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase